Aadi Bioscience Appoints David Dornan, PhD as Chief Scientific Officer (CSO)
Position
Chief Scientific Officer
Company
Whitehawk Therapeutics, Inc.
MorristownBiotechnologyHealth CareTherapeuticsDescription
Aadi Bioscience, Inc (NASDAQ: AADI) has announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer (CSO). Dr Dornan brings over two decades of experience in oncology drug discovery and development, specifically in antibody-drug conjugates (ADCs) and other targeted cancer therapies.
Quick answer
Aadi Bioscience Appoints David Dornan, PhD as Chief Scientific Officer (CSO) (February 20, 2025). Whitehawk Therapeutics, Inc. is based in Morristown, New Jersey, United States.
- Who is the new Chief Scientific Officer at Whitehawk Therapeutics, Inc?
- Whitehawk Therapeutics, Inc. named David Dornan Chief Scientific Officer, announced February 20, 2025.
- What did Whitehawk Therapeutics, Inc. announce on February 20, 2025?
- Aadi Bioscience, Inc (NASDAQ: AADI) has announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer (CSO). Dr Dornan brings over two decades of experience in oncology drug discovery and development, specifically in antibody-drug conjugates (ADCs) and other targeted cancer therapies.
- Where is Whitehawk Therapeutics, Inc. based?
- Whitehawk Therapeutics, Inc. is based in Morristown, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (February 21, 2025), Tivic (February 24, 2025), Cerenome, Inc. (February 24, 2025) and Pfizer (February 24, 2025) also announced leadership changes within 45 days of Whitehawk Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
- Michael K. Handley Appointed as President of Tivic Biopharma and Chief Operating Officer of Tivic Health (February 24, 2025)
- Plus Therapeutics Appoints Michael Rosol, Ph.D., as Chief Development Officer (February 24, 2025)
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Crescent Biopharma, Inc. Appoints Wenjie Cheng as Senior Vice President of Technical Operations, Ryan Lynch as Chief Accounting Officer, and Barbara Bispham as General Counsel (February 24, 2025)
- Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer (February 16, 2025)
Who to call at Whitehawk Therapeutics, Inc., and when
A new leader at Whitehawk Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Whitehawk Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Whitehawk Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Whitehawk Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Whitehawk Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Whitehawk Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.